Protein active in humoral hypercalcemia of malignancy-PTHRP
US5116952A · kind A · utility
30Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 1988 |
| Grant date | May 26, 1992 |
| Priority date | — |
| Expiry date | May 9, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substantially pure proteins active in humoral hypercalcemia of malignancy (PTHrP) and sub-units and fragments thereof. Antibody reagents capable of binding to epitopes of PTHrP. Methods and kits for the detection of PTHrP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.